Hyperfine’s (HYPR) Buy Rating Reiterated at BTIG Research

BTIG Research reiterated their buy rating on shares of Hyperfine (NASDAQ:HYPR) in a research report report published on Monday morning, Marketbeat reports. They currently have a $2.00 target price on the stock.

A number of other research analysts have also recently commented on HYPR. B. Riley Financial reiterated a “buy” rating and issued a $1.60 price target (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperfine in a research report on Friday, July 17th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Hyperfine currently has an average rating of “Hold” and a consensus target price of $2.03.

Hyperfine Stock Down 3.4%

Shares of NASDAQ HYPR opened at $0.77 on Monday. The company has a market cap of $82.10 million, a price-to-earnings ratio of -2.04 and a beta of 1.41. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. Hyperfine has a 12 month low of $0.77 and a 12 month high of $2.22. The stock has a 50-day moving average price of $0.91 and a two-hundred day moving average price of $1.19.

Hyperfine (NASDAQ:HYPR) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.09). The company had revenue of $3.90 million for the quarter, compared to the consensus estimate of $4.13 million. Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. As a group, analysts forecast that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Institutional Trading of Hyperfine

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Catalio Capital Management LP grew its position in shares of Hyperfine by 92.8% in the 4th quarter. Catalio Capital Management LP now owns 1,320,041 shares of the company’s stock valued at $1,293,000 after buying an additional 635,500 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Hyperfine in the second quarter valued at about $419,000. Renaissance Technologies LLC raised its position in shares of Hyperfine by 100.2% during the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after acquiring an additional 365,490 shares during the last quarter. Walleye Capital LLC raised its position in shares of Hyperfine by 3.4% during the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock worth $242,000 after acquiring an additional 7,330 shares during the last quarter. Finally, Tortoise Investment Management LLC lifted its stake in shares of Hyperfine by 60.0% in the fourth quarter. Tortoise Investment Management LLC now owns 72,000 shares of the company’s stock worth $71,000 after acquiring an additional 27,000 shares during the period. 15.03% of the stock is currently owned by institutional investors and hedge funds.

About Hyperfine

Hyperfine, Inc is a medical technology company that develops portable magnetic resonance imaging (MRI) systems for use at the point of care. Its flagship product, the Swoop Portable MR Imaging System, is designed to bring brain imaging directly to patients in settings such as intensive care units, emergency departments, hospitals and other clinical environments.

The Swoop system is intended to support rapid assessment of neurological conditions, including stroke, brain injury and other disorders.